RSS   Newsletter   Contact   Advertise with us
Post Online Media

Altimmune appoints Mitchel Sayare as executive chairman

AltimmuneAltimmune, a clinical-stage immunotherapeutics company, announced it has appointed Mitchel Sayare as executive chairman of the board.


Dr. Sayare originally joined PharmAthene’s Board of Directors in April 2010.

Dr. Sayare became Chairman of merger partner Altimmune’s Board of Directors in January 2018.

The Company announced the hiring of José Ochoa as Chief Business Officer of Altimmune.

Mr. Ochoa joined Altimmune from IDT Biologika Corporation where he served as Chief Business Officer & Head of Animal Health Americas.

Prior to IDT, Mr. Ochoa spent over a decade at Emergent BioSolutions, having served as Vice President Strategic Alliances, and as Vice President, Business Development & Alliance Management, where he led mergers & acquisitions, in-licensing, corporate strategy and alliance management functions.

Mr. Ochoa initially served as General Counsel at BioPort (Emergent’s predecessor) and General Counsel for East West Resources Corporation.

 

 LATEST MOVES FROM Maryland 


 
 

POST Online Media does not use cookies to collect information about visitors.   OK, hide this message   Third party ads may be using cookies, you can see how here.